Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12831 | 878 | 25.9 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
9 | 3 | CHEMISTRY, ORGANIC//JOURNAL OF HETEROCYCLIC CHEMISTRY//KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII | 135847 |
2105 | 2 | QUINOXALINE//1 5 BENZODIAZEPINES//1 5 BENZOTHIAZEPINE | 5138 |
12831 | 1 | PYRROLOBENZODIAZEPINE//PYRROLO2 1 C1 4BENZODIAZEPINES//CANC UK GENE TARGETED DRUG DESIGN GRP | 878 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PYRROLOBENZODIAZEPINE | authKW | 1908190 | 7% | 84% | 65 |
2 | PYRROLO2 1 C1 4BENZODIAZEPINES | authKW | 776264 | 3% | 89% | 25 |
3 | CANC UK GENE TARGETED DRUG DESIGN GRP | address | 528971 | 2% | 89% | 17 |
4 | GENE TARGETED DRUG DESIGN GRP | address | 445137 | 2% | 80% | 16 |
5 | SPIROGEN LTD | address | 281691 | 1% | 90% | 9 |
6 | PYRROLOBENZODIAZEPINE DIMERS | authKW | 278215 | 1% | 100% | 8 |
7 | SJG 136 | authKW | 247300 | 1% | 89% | 8 |
8 | GENE TARGETING DRUG DESIGN GRP | address | 178851 | 1% | 86% | 6 |
9 | PYRROLO1 4BENZODIAZEPINES | authKW | 178851 | 1% | 86% | 6 |
10 | CRC GENE TARGETED DRUG DESIGN GRP | address | 173884 | 1% | 100% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Organic | 16700 | 62% | 0% | 540 |
2 | Chemistry, Medicinal | 3911 | 20% | 0% | 177 |
3 | Pharmacology & Pharmacy | 211 | 12% | 0% | 101 |
4 | Chemistry, Multidisciplinary | 85 | 9% | 0% | 83 |
5 | Chemistry, Applied | 12 | 2% | 0% | 17 |
6 | Microbiology | 12 | 3% | 0% | 27 |
7 | Crystallography | 10 | 2% | 0% | 14 |
8 | Biochemistry & Molecular Biology | 10 | 8% | 0% | 70 |
9 | Biotechnology & Applied Microbiology | 5 | 3% | 0% | 23 |
10 | Oncology | 4 | 3% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC UK GENE TARGETED DRUG DESIGN GRP | 528971 | 2% | 89% | 17 |
2 | GENE TARGETED DRUG DESIGN GRP | 445137 | 2% | 80% | 16 |
3 | SPIROGEN LTD | 281691 | 1% | 90% | 9 |
4 | GENE TARGETING DRUG DESIGN GRP | 178851 | 1% | 86% | 6 |
5 | CRC GENE TARGETED DRUG DESIGN GRP | 173884 | 1% | 100% | 5 |
6 | YORKSHIRE CANC DRUG DESIGN | 134129 | 1% | 43% | 9 |
7 | EA IMT 6306 | 104331 | 0% | 100% | 3 |
8 | UATRS ANGLE ALLAL FASSI FAR | 104331 | 0% | 100% | 3 |
9 | CANC UK DRUG DNA INTERACT GRP | 90399 | 1% | 20% | 13 |
10 | CR UK DRUG DNA INTERACT GRP | 86937 | 1% | 50% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF HETEROCYCLIC CHEMISTRY | 27090 | 10% | 1% | 92 |
2 | FARMACO-EDIZIONE SCIENTIFICA | 10708 | 2% | 2% | 16 |
3 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 4911 | 7% | 0% | 60 |
4 | FARMACO | 4447 | 2% | 1% | 15 |
5 | TETRAHEDRON LETTERS | 3277 | 10% | 0% | 84 |
6 | TETRAHEDRON | 2887 | 6% | 0% | 56 |
7 | HETEROCYCLES | 2661 | 4% | 0% | 32 |
8 | HETEROCYCLIC COMMUNICATIONS | 2181 | 1% | 1% | 10 |
9 | JOURNAL OF MEDICINAL CHEMISTRY | 1937 | 4% | 0% | 35 |
10 | JOURNAL OF ANTIBIOTICS | 1665 | 2% | 0% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PYRROLOBENZODIAZEPINE | 1908190 | 7% | 84% | 65 | Search PYRROLOBENZODIAZEPINE | Search PYRROLOBENZODIAZEPINE |
2 | PYRROLO2 1 C1 4BENZODIAZEPINES | 776264 | 3% | 89% | 25 | Search PYRROLO2+1+C1+4BENZODIAZEPINES | Search PYRROLO2+1+C1+4BENZODIAZEPINES |
3 | PYRROLOBENZODIAZEPINE DIMERS | 278215 | 1% | 100% | 8 | Search PYRROLOBENZODIAZEPINE+DIMERS | Search PYRROLOBENZODIAZEPINE+DIMERS |
4 | SJG 136 | 247300 | 1% | 89% | 8 | Search SJG+136 | Search SJG+136 |
5 | PYRROLO1 4BENZODIAZEPINES | 178851 | 1% | 86% | 6 | Search PYRROLO1+4BENZODIAZEPINES | Search PYRROLO1+4BENZODIAZEPINES |
6 | PBDS | 173884 | 1% | 100% | 5 | Search PBDS | Search PBDS |
7 | PYRROLOBENZOTHIADIAZEPINE | 173884 | 1% | 100% | 5 | Search PYRROLOBENZOTHIADIAZEPINE | Search PYRROLOBENZOTHIADIAZEPINE |
8 | DNA BINDING AFFINITY | 170084 | 2% | 33% | 15 | Search DNA+BINDING+AFFINITY | Search DNA+BINDING+AFFINITY |
9 | DNA BINDING ABILITY | 158973 | 1% | 57% | 8 | Search DNA+BINDING+ABILITY | Search DNA+BINDING+ABILITY |
10 | 1 4 BENZODIAZEPINE | 151192 | 1% | 43% | 10 | Search 1+4+BENZODIAZEPINE | Search 1+4+BENZODIAZEPINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ANTONOW, D , THURSTON, DE , (2011) SYNTHESIS OF DNA-INTERACTIVE PYRROLO[2,1-C][1,4]BENZODIAZEPINES (PBDS).CHEMICAL REVIEWS. VOL. 111. ISSUE 4. P. 2815 -2864 | 166 | 87% | 47 |
2 | GERRATANA, B , (2012) BIOSYNTHESIS, SYNTHESIS, AND BIOLOGICAL ACTIVITIES OF PYRROLOBENZODIAZEPINES.MEDICINAL RESEARCH REVIEWS. VOL. 32. ISSUE 2. P. 254 -293 | 102 | 78% | 24 |
3 | VARVOUNIS, G , (2016) AN UPDATE ON THE SYNTHESIS OF PYRROLO[1,4]BENZODIAZEPINES.MOLECULES. VOL. 21. ISSUE 2. P. - | 68 | 79% | 0 |
4 | CIPOLLA, L , ARAUJO, AC , AIROLDI, C , BINI, D , (2009) PYRROLO[2,1-C][1,4]BENZODIAZEPINE AS A SCAFFOLD FOR THE DESIGN AND SYNTHESIS OF ANTI-TUMOUR DRUGS.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 1. P. 1-31 | 84 | 67% | 40 |
5 | THURSTON, DE , BOSE, DS , (1994) SYNTHESIS OF DNA-INTERACTIVE PYRROLO[2,1-C][1,4]BENZODIAZEPINES.CHEMICAL REVIEWS. VOL. 94. ISSUE 2. P. 433-465 | 87 | 85% | 226 |
6 | GILL, RK , KAUSHIK, SO , CHUGH, J , BANSAL, S , SHAH, A , BARIWAL, J , (2014) RECENT DEVELOPMENT IN [1,4]BENZODIAZEPINES AS POTENT ANTICANCER AGENTS: A REVIEW.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 14. ISSUE 3. P. 229 -256 | 64 | 57% | 1 |
7 | JACKSON, PJM , JAMES, CH , JENKINS, TC , RAHMAN, KM , THURSTON, DE , (2014) COMPUTATIONAL STUDIES SUPPORT THE ROLE OF THE C7-SIBIROSAMINE SUGAR OF THE PYRROLOBENZODIAZEPINE (PBD) SIBIROMYCIN IN TRANSCRIPTION FACTOR INHIBITION.ACS CHEMICAL BIOLOGY. VOL. 9. ISSUE 10. P. 2432 -2440 | 41 | 87% | 2 |
8 | HARTLEY, JA , (2011) THE DEVELOPMENT OF PYRROLOBENZODIAZEPINES AS ANTITUMOUR AGENTS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 20. ISSUE 6. P. 733 -744 | 43 | 73% | 26 |
9 | KAMAL, A , AZEEZA, S , BHARATHI, EV , MALIK, MS , SHETTI, RVCRNC , (2010) SEARCH FOR NEW AND NOVEL CHEMOTHERAPEUTICS FOR THE TREATMENT OF HUMAN MALIGNANCIES.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 5. P. 405-435 | 84 | 39% | 15 |
10 | RAHMAN, KM , JAMES, CH , BUI, TTT , DRAKE, AF , THURSTON, DE , (2011) OBSERVATION OF A SINGLE-STRANDED DNA/PYRROLOBENZODIAZEPINE ADDUCT.JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. VOL. 133. ISSUE 48. P. 19376-19385 | 35 | 88% | 6 |
Classes with closest relation at Level 1 |